Microcystic adnexal carcinoma: An immunohistochemical reappraisal

Mai P. Hoang, Karen A. Dresser, Payal Kapur, Whitney A. High, Meera Mahalingam

Research output: Contribution to journalArticle

65 Citations (Scopus)

Abstract

Even though immunohistochemical comparisons of microcystic adnexal carcinoma vs infiltrative basal cell carcinoma and desmoplastic trichoepithelioma exist, they are mostly restricted to the use of a single stain. In addition, a comparison with squamous cell carcinoma has not been reported previously. In this study, we compare the expression of cytokeratin (CK) 15, CK7, CK20, CK903, carcinoembryonic antigen (CEA), CD10, CD15 and BerEP4 in 13 microcystic adnexal carcinoma, eight desmoplastic trichoepithelioma, 10 infiltrative basal cell carcinoma, and eight squamous cell carcinoma of which five exhibited ductal differentiation. We found that the majority of microcystic adnexal carcinoma (92%) and desmoplastic trichoepithelioma (100%) cases expressed CK15 while the infiltrative basal cell carcinoma and squamous cell carcinoma cases were all negative. Forty percent of infiltrative basal cell carcinoma expressed CK7; while only two microcystic adnexal carcinoma cases (15%) and one squamous cell carcinoma with ductal differentiation (12%) expressed CK7 in the remaining three tumor categories. None of the desmoplastic trichoepithelioma expressed CK7. All tumors were strongly positive for CK903. While the neoplastic cells were negative, luminal staining of ductal structures was noted for CK7, CD15 and CEA in some of the microcystic adnexal carcinoma, desmoplastic trichoepithelioma and squamous cell carcinoma with ductal differentiation cases. Sixty percent of infiltrative basal cell carcinoma, 31% of microcystic adnexal carcinoma, and 25% of squamous cell carcinoma express CD10. BerEP4 expression was noted in 38% of microcystic adnexal carcinoma, 57% of desmoplastic trichoepithelioma, 100% of infiltrative basal cell carcinoma, and 38% of squamous cell carcinoma. In conclusion, we found CK15 to be a useful marker in distinguishing microcystic adnexal carcinoma from infiltrative basal cell carcinoma and squamous cell carcinoma with ductal differentiation. Our experience indicates that microcystic adnexal carcinoma and desmoplastic trichoepithelioma have a similar immunohistochemical profile that is, CK15+ and BerEP4+/-; thus, additional studies are needed to separate these two entities.

Original languageEnglish (US)
Pages (from-to)178-185
Number of pages8
JournalModern Pathology
Volume21
Issue number2
DOIs
StatePublished - Feb 2008

Fingerprint

Basal Cell Carcinoma
Squamous Cell Carcinoma
Carcinoma
Carcinoembryonic Antigen
Keratin-15
CD15 Antigens
Negative Staining
Neoplasms
Coloring Agents

Keywords

  • BerEP4
  • Cytokeratin 15
  • Desmoplastic trichoepithelioma
  • Infiltrative basal cell carcinoma
  • Microcystic adnexal carcinoma
  • Squamous cell carcinoma with ductal differentiation

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Microcystic adnexal carcinoma : An immunohistochemical reappraisal. / Hoang, Mai P.; Dresser, Karen A.; Kapur, Payal; High, Whitney A.; Mahalingam, Meera.

In: Modern Pathology, Vol. 21, No. 2, 02.2008, p. 178-185.

Research output: Contribution to journalArticle

Hoang, MP, Dresser, KA, Kapur, P, High, WA & Mahalingam, M 2008, 'Microcystic adnexal carcinoma: An immunohistochemical reappraisal', Modern Pathology, vol. 21, no. 2, pp. 178-185. https://doi.org/10.1038/modpathol.3801000
Hoang, Mai P. ; Dresser, Karen A. ; Kapur, Payal ; High, Whitney A. ; Mahalingam, Meera. / Microcystic adnexal carcinoma : An immunohistochemical reappraisal. In: Modern Pathology. 2008 ; Vol. 21, No. 2. pp. 178-185.
@article{604bbaace3b049a0b779b33257ff71ff,
title = "Microcystic adnexal carcinoma: An immunohistochemical reappraisal",
abstract = "Even though immunohistochemical comparisons of microcystic adnexal carcinoma vs infiltrative basal cell carcinoma and desmoplastic trichoepithelioma exist, they are mostly restricted to the use of a single stain. In addition, a comparison with squamous cell carcinoma has not been reported previously. In this study, we compare the expression of cytokeratin (CK) 15, CK7, CK20, CK903, carcinoembryonic antigen (CEA), CD10, CD15 and BerEP4 in 13 microcystic adnexal carcinoma, eight desmoplastic trichoepithelioma, 10 infiltrative basal cell carcinoma, and eight squamous cell carcinoma of which five exhibited ductal differentiation. We found that the majority of microcystic adnexal carcinoma (92{\%}) and desmoplastic trichoepithelioma (100{\%}) cases expressed CK15 while the infiltrative basal cell carcinoma and squamous cell carcinoma cases were all negative. Forty percent of infiltrative basal cell carcinoma expressed CK7; while only two microcystic adnexal carcinoma cases (15{\%}) and one squamous cell carcinoma with ductal differentiation (12{\%}) expressed CK7 in the remaining three tumor categories. None of the desmoplastic trichoepithelioma expressed CK7. All tumors were strongly positive for CK903. While the neoplastic cells were negative, luminal staining of ductal structures was noted for CK7, CD15 and CEA in some of the microcystic adnexal carcinoma, desmoplastic trichoepithelioma and squamous cell carcinoma with ductal differentiation cases. Sixty percent of infiltrative basal cell carcinoma, 31{\%} of microcystic adnexal carcinoma, and 25{\%} of squamous cell carcinoma express CD10. BerEP4 expression was noted in 38{\%} of microcystic adnexal carcinoma, 57{\%} of desmoplastic trichoepithelioma, 100{\%} of infiltrative basal cell carcinoma, and 38{\%} of squamous cell carcinoma. In conclusion, we found CK15 to be a useful marker in distinguishing microcystic adnexal carcinoma from infiltrative basal cell carcinoma and squamous cell carcinoma with ductal differentiation. Our experience indicates that microcystic adnexal carcinoma and desmoplastic trichoepithelioma have a similar immunohistochemical profile that is, CK15+ and BerEP4+/-; thus, additional studies are needed to separate these two entities.",
keywords = "BerEP4, Cytokeratin 15, Desmoplastic trichoepithelioma, Infiltrative basal cell carcinoma, Microcystic adnexal carcinoma, Squamous cell carcinoma with ductal differentiation",
author = "Hoang, {Mai P.} and Dresser, {Karen A.} and Payal Kapur and High, {Whitney A.} and Meera Mahalingam",
year = "2008",
month = "2",
doi = "10.1038/modpathol.3801000",
language = "English (US)",
volume = "21",
pages = "178--185",
journal = "Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc",
issn = "0893-3952",
publisher = "Nature Publishing Group",
number = "2",

}

TY - JOUR

T1 - Microcystic adnexal carcinoma

T2 - An immunohistochemical reappraisal

AU - Hoang, Mai P.

AU - Dresser, Karen A.

AU - Kapur, Payal

AU - High, Whitney A.

AU - Mahalingam, Meera

PY - 2008/2

Y1 - 2008/2

N2 - Even though immunohistochemical comparisons of microcystic adnexal carcinoma vs infiltrative basal cell carcinoma and desmoplastic trichoepithelioma exist, they are mostly restricted to the use of a single stain. In addition, a comparison with squamous cell carcinoma has not been reported previously. In this study, we compare the expression of cytokeratin (CK) 15, CK7, CK20, CK903, carcinoembryonic antigen (CEA), CD10, CD15 and BerEP4 in 13 microcystic adnexal carcinoma, eight desmoplastic trichoepithelioma, 10 infiltrative basal cell carcinoma, and eight squamous cell carcinoma of which five exhibited ductal differentiation. We found that the majority of microcystic adnexal carcinoma (92%) and desmoplastic trichoepithelioma (100%) cases expressed CK15 while the infiltrative basal cell carcinoma and squamous cell carcinoma cases were all negative. Forty percent of infiltrative basal cell carcinoma expressed CK7; while only two microcystic adnexal carcinoma cases (15%) and one squamous cell carcinoma with ductal differentiation (12%) expressed CK7 in the remaining three tumor categories. None of the desmoplastic trichoepithelioma expressed CK7. All tumors were strongly positive for CK903. While the neoplastic cells were negative, luminal staining of ductal structures was noted for CK7, CD15 and CEA in some of the microcystic adnexal carcinoma, desmoplastic trichoepithelioma and squamous cell carcinoma with ductal differentiation cases. Sixty percent of infiltrative basal cell carcinoma, 31% of microcystic adnexal carcinoma, and 25% of squamous cell carcinoma express CD10. BerEP4 expression was noted in 38% of microcystic adnexal carcinoma, 57% of desmoplastic trichoepithelioma, 100% of infiltrative basal cell carcinoma, and 38% of squamous cell carcinoma. In conclusion, we found CK15 to be a useful marker in distinguishing microcystic adnexal carcinoma from infiltrative basal cell carcinoma and squamous cell carcinoma with ductal differentiation. Our experience indicates that microcystic adnexal carcinoma and desmoplastic trichoepithelioma have a similar immunohistochemical profile that is, CK15+ and BerEP4+/-; thus, additional studies are needed to separate these two entities.

AB - Even though immunohistochemical comparisons of microcystic adnexal carcinoma vs infiltrative basal cell carcinoma and desmoplastic trichoepithelioma exist, they are mostly restricted to the use of a single stain. In addition, a comparison with squamous cell carcinoma has not been reported previously. In this study, we compare the expression of cytokeratin (CK) 15, CK7, CK20, CK903, carcinoembryonic antigen (CEA), CD10, CD15 and BerEP4 in 13 microcystic adnexal carcinoma, eight desmoplastic trichoepithelioma, 10 infiltrative basal cell carcinoma, and eight squamous cell carcinoma of which five exhibited ductal differentiation. We found that the majority of microcystic adnexal carcinoma (92%) and desmoplastic trichoepithelioma (100%) cases expressed CK15 while the infiltrative basal cell carcinoma and squamous cell carcinoma cases were all negative. Forty percent of infiltrative basal cell carcinoma expressed CK7; while only two microcystic adnexal carcinoma cases (15%) and one squamous cell carcinoma with ductal differentiation (12%) expressed CK7 in the remaining three tumor categories. None of the desmoplastic trichoepithelioma expressed CK7. All tumors were strongly positive for CK903. While the neoplastic cells were negative, luminal staining of ductal structures was noted for CK7, CD15 and CEA in some of the microcystic adnexal carcinoma, desmoplastic trichoepithelioma and squamous cell carcinoma with ductal differentiation cases. Sixty percent of infiltrative basal cell carcinoma, 31% of microcystic adnexal carcinoma, and 25% of squamous cell carcinoma express CD10. BerEP4 expression was noted in 38% of microcystic adnexal carcinoma, 57% of desmoplastic trichoepithelioma, 100% of infiltrative basal cell carcinoma, and 38% of squamous cell carcinoma. In conclusion, we found CK15 to be a useful marker in distinguishing microcystic adnexal carcinoma from infiltrative basal cell carcinoma and squamous cell carcinoma with ductal differentiation. Our experience indicates that microcystic adnexal carcinoma and desmoplastic trichoepithelioma have a similar immunohistochemical profile that is, CK15+ and BerEP4+/-; thus, additional studies are needed to separate these two entities.

KW - BerEP4

KW - Cytokeratin 15

KW - Desmoplastic trichoepithelioma

KW - Infiltrative basal cell carcinoma

KW - Microcystic adnexal carcinoma

KW - Squamous cell carcinoma with ductal differentiation

UR - http://www.scopus.com/inward/record.url?scp=38649096944&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38649096944&partnerID=8YFLogxK

U2 - 10.1038/modpathol.3801000

DO - 10.1038/modpathol.3801000

M3 - Article

C2 - 18065959

AN - SCOPUS:38649096944

VL - 21

SP - 178

EP - 185

JO - Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

JF - Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

SN - 0893-3952

IS - 2

ER -